| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1097-0142(20010715)92:2<349::AID-CNCR1329>3.0.CO;2-C |
| P698 | PubMed publication ID | 11466689 |
| P2093 | author name string | T Hara | |
| T Sugimoto | |||
| A Nagasaki | |||
| S Miyazaki | |||
| N Handa | |||
| K Kawakami | |||
| H Eguchi | |||
| H Mizote | |||
| H Takamatsu | |||
| J Okamura | |||
| M Tsuneyoshi | |||
| S Suita | |||
| T Tajiri | |||
| Y Sera | |||
| N Kurosaki | |||
| Committee for Pediatric Solid Malignant Tumors in the Kyushu Area | |||
| P2860 | cites work | A proposed staging for children with neuroblastoma.Children's cancer study group A | Q34701554 |
| Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas | Q34711600 | ||
| Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears. United Kingdom Children's Cancer Study Group | Q35978227 | ||
| Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening | Q40839046 | ||
| Mass screening for neuroblastoma at 6 months of age: difficult to justify | Q44809855 | ||
| Flow cytometric DNA analysis of Neuroblastoma and Ganglioneuroma. A 10-year retrospective study | Q52553497 | ||
| High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma | Q63874527 | ||
| Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children | Q67927081 | ||
| Neuroblastoma. Mass screening for early detection and its prognosis | Q71349911 | ||
| Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan | Q71520639 | ||
| How to deal with advanced cases of neuroblastoma detected by mass screening: a report from the Pediatric Oncology Study Group of the Kyushu area of Japan | Q72070117 | ||
| One hundred neuroblastomas detected through a mass screening system in Japan | Q72861796 | ||
| Natural history of neuroblastoma found by mass screening | Q73233368 | ||
| Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification | Q73256557 | ||
| Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma | Q73734127 | ||
| Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan | Q74601358 | ||
| Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas | Q93621132 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Japan | Q17 |
| neuroblastoma | Q938205 | ||
| P304 | page(s) | 349-353 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan | |
| P478 | volume | 92 |
| Q80510573 | Biology and therapy of malignant solid tumors in childhood |
| Q36614178 | MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening |
| Q44701993 | Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment |
| Q34180699 | Neuroblastoma: biological insights into a clinical enigma |
| Q36144256 | Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistance |
| Q83467384 | Trend in the Number of Registrations for Neuroblastoma in Japan |
Search more.